PDLIM1 and nonpapillary renal cell carcinoma: Functionally, PDLIM1 overexpression suppressed, whereas PDLIM1 knockdown promoted tube formation.<h4>Conclusions</h4>This study developed and validated an angiogenesis-related radiogenomics model that accurately predicts OS in ccRCC patients and provides potential therapeutic targets for anti-angiogenic therapy.